It was previously reported that the steroid hormones estrone, cortisone, and hydrocortisone markedly increased the susceptibility of mice to lethal infection by MM virus (a member of the encephalomyocarditis group of viruses), whereas prednisolone, progesterone, and testosterone had no effect. Progeny virus appeared in the sera and brains of estronetreated animals 48 h earlier than in untreated controls (4) . In the present study, we investigated the possibility that the observed virus infection-enhancing (VIE) activity may be a reflection of an alteration of the permeability of the peritoneal membranes, permitting the virus to reach target organs more rapidly via the vascular system. In addition, the effect of various steroids on the lethal infection of mice by Mayaro virus (group A arbovirus) and a comparison of the course taken by MM and Mayaro viruses in estrone-treated and untreated mice were determined.
MATERIALS AND METHODS
Viruses. Stock suspensions of MM and Mayaro viruses were prepared and titrated in L cell monolayer cultures by the method previously described (6) . The mean lethal dose (LD50) of each virus preparation in mice was computed by the method of Reed and Muench (9) 10. Steroids. Estrone, progesterone, hydrocortisone, prednisolone acetate, and testosterone were purchased from Upjohn Laboratories. All steroids, except progesterone which was in oil, were in aqueous solutions as described previously (4) . Each hormone was injected intraperitoneally at the doses indicated.
Measurement of virus uptake from peritoneal cavity. Twenty-four hours after a dose of 2.0 mg of estrone each, treated mice and normal controls received 2.7 x 107 plaque-forming units (PFU) of the test virus in 0.2 ml of Hanks balanced salt solution (HBS) by the intraperitoneal route. At intervals, mice were decapitated and their blood was collected in individual tubes containing 0.1 ml of heparin solution (1,000 U.S.P. units/ml, Riker Laboratories, Northridge, Calif.). Peritoneal washings, also from individual mice, were obtained by injecting 2 ml of HBS containing 1 mg of bovine serum albumin per ml, massaging the abdomen, and removing the fluid. All samples were immediately frozen and stored at -40 C. Just prior to plaque assay, all samples were exposed to two cycles of rapid freezing and thawing.
Statistical analysis. Significance of the difference was determined by chi-square or by t test as indicated. Differences results (Table 3) show that treatment with any of the steroids resulted in increased mortality. In addition, testosterone, cortisone, and estrone significantly decreased the mean survival time. These results contrast with those previously reported using MM virus as the infectious agent (4) . In those studies, progesterone, prednisolone, and testosterone had no effect on mortality rate or survival time.
Replication of Mayaro and MM viruses in hormone-treated and untreated mice. The finding that certain hormones (prednisolone, progesterone, testosterone) differed in their effect on lethal infection by MM and Mayaro bChi-square probability that mortality rate differs from that of control group.
Mean survival time.
dt Test probability that MST differs from that o-f control group; NS, not significant (P > 0.05).
viruses suggested that, during the initial stages, infection by these viruses might involve different target tissues. The following experiment was designed to investigate this possibility and to determine the effect of estrone on the replication of each virus in the various tissues. Estrone (1 mg per mouse) was administered to one-half of a large group of mice. Twenty-four hours later all of the animals were challenged with either MM or Mayaro viruses (2 LD5O). At various time intervals, 10 mice from each group were sacrificed, and the sera, brains, and selected organs were collected and pooled. The organs were homogenized in HBS and centrifuged to remove particulate material. The sera and clarified extracts were then assayed for virus content. Representative portions only of these tissues were examined, but the results are calculated and expressed as virus content of the entire organ. Total blood volume was estimated to be 2 ml. The results are given in Tables 4 and   5 .
In control animals, MM virus was not found in significant amounts in any of the tissues tested until 72 h after virus inoculation (Table  4) . Except for the brain, it apparently replicated only in the liver and was transiently found in the other organs and blood. After estrone treatment, the virus was readily isolated from several tissues as early as 4 h after virus injection. By 24 h, virus was found in all of the tissues tested and apparently replicated in the intestines, liver, spleen, and brain. With the exception of the brain where final virus titers in control and test animals were within 0.5 log of each other, much more virus was produced in estrone-treated mice. Table 5 gives the data obtained when Mayaro virus was the infectious agent. They suggest that the initial replication of the virus occurred in the intestines. By 48 h, the virus was found in all of the tissues tested and apparently replicated in all of them, although the virus found in the blood could be reflecting the release of the agent from other tissues. Estrone treatment stimulated viral replication, resulting in the earlier appearance of the virus at higher titers than those eventually attained in control animals.
These data show that Mayaro virus produces a more disseminated infection than does MM virus. Estrone stimulates the replication of both viruses and appears to make previously resistant tissues susceptible to MM virus. DISCUSSION Previous studies indicate that certain steroids enhance experimental viral infections, whereas others have little or no effect (1, 2, 4, 8, 10, 11 ). The present study, however, has shown that the VIE activity of a hormone may be dependent on the viral agent used for challenge. Thus, prednisolone, progesterone, and testosterone, which were previously reported to have no effect on MM virus infection (4) were found to exhibit VIE activity when Mayaro virus was the infectious agent (see Table 3 ). Interference with the interferon system has been suggested as a possible mechanism for the VIE activity of a hormone (5). Since progesterone and testosterone were found to have no effect on interferon synthesis (7), it is clear that this is not the only mechanism involved. Other mechanisms can now be suggested. The permeability of the peritoneal membrane appears to be altered, allowing the virus to enter the vascular system and reach target tissues more rapidly. It also appears that the membranes of other cells are altered, making them more susceptible to virus infection. This effect was evident when MM virus was the infectious agent (see Table 4 ). In addition, viral replication was stimulated, resulting in the earlier appearance of high-titered progeny virus.
A hormone could induce some or all of the above changes. Expression of the VIE activity would then depend on the characteristics of the virus. MM virus, for instance, is a good interferon inducer, is very sensitive to the action of interferon (3), and initially replicates in relatively few tissues. When such a virus is used, only those hormones which interfere with the interferon system would be expected to show VIE activity. Mayaro virus, on the other hand, is sensitive to the action of interferon but is a relatively poor interferon inducer (unpublished data). During the course of normal Mayaro virus infection, very little interferon is produced, and it does not appear to play a significant role in combating the infection process. In addition, Mayaro virus initially infects many tissues (see Table 5 Table 4 for procedure.
h Seven of 10 mice survived for 96 h. By 120 h, there were no survivors in the estrone-treated group.
C ND, Not done.
clear. After estrogen treatment, the virus is quickly taken up by the vascular system and transported to tissues which are now more susceptible to virus infection. At this stage, the interferon system is essentially nonfunctional so the virus escapes this line of defense. Virus replication is stimulated, allowing the viral agent to quickly reach the proper threshold levels for brain infection. We are currently investigating the mechanism(s) involved in the stimulation of virus replication by using an in vitro hormone-cell system.
